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Abstract
Purpose Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemo-
therapy in ER-positive, HER2-negative, early-stage breast cancer. As health literacy and numeracy skills in the general 
population are poor, healthcare professionals (HCPs) require a wide repertoire of communication skills to explain clearly 
risk of recurrence scores (RSs) and uncertainty. We developed and evaluated an educational program for HCPs discussing 
GEP test results and adjuvant treatment.
Methods Eight-hour workshops contained elements aimed at improving knowledge, communication skills and self-aware-
ness; these included the science underpinning GEP tests, an interactive risk psychology lecture, exercises and facilitated 
group discussions regarding seven filmed scenarios involving discussions about high, intermediate and low RSs. Attendees 
were recorded explaining RSs with patient simulators pre and post workshop. Researchers, blinded to time point, analysed 
recordings using a study-specific scoring system. Primary objective outcomes were improvements post workshop in HCPs’ 
competence and confidence when communicating 17 pre-specified key information areas. We estimated odds ratios (OR) 
using conditional logistic regression to compare pre- and post-workshop scores.
Results 65 HCPs attended. Objective analyses revealed significant positive shifts post workshop which included explain-
ing GEP tests (OR 2.98; 95% CI 1.38–6.42; P = .001), recurrence RSs (OR 3.99; 95% CI 1.72–9.25; P < .001), benefits of 
chemotherapy (OR 3.99; 95% CI 1.82–8.75; P < .001; and harms OR 2.31; 95% CI 1.37–3.92; P < .001) using jargon free 
language (OR 5.29; 95% CI 2.27–12.35; P < .001). Patient simulator assessments also showed significant improvements as 
did HCPs’ self-assessments and ratings of their self-confidence when discussing different GEP tests with diverse patient 
types (P < .001).
Conclusion These short, intensive, interactive TARGET workshops significantly improved HCPs’ communication about 
GEP results in ways likely to promote more informed decision-making by patients about chemotherapy.
Keywords Risk of recurrence · Genomic test results · Breast cancer · Chemotherapy · Communication
Introduction
There have been exciting advances in diagnostics, surgi-
cal and radiotherapy techniques and systemic therapies for 
women with early-stage breast cancer (EBC). Better under-
standing about the molecular biology of cancer has permit-
ted more targeted treatment, and thus many patients have 
genuine prospects of cure or living longer. Most patients 
with cancer want collaborative roles in treatment decision-
making [1], but discussions about the logic and rationale 
behind treatment recommendations have become increas-
ingly complex and demand excellent communication skills. 
Decision-making about adjuvant chemotherapy in particular 
requires careful balancing between likely absolute benefits 
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in terms of preventing recurrence versus the unpleasant side 
effects and inconvenience of treatment. Explaining risks 
and benefits to patients is never easy and health literacy and 
numeracy skills are frequently poor in the general popula-
tions of the US, Canada, Australia and EU [2, 3]. Percep-
tions about health risk information are strongly related to 
numeracy so women with inadequate numeracy skills are 
more likely to overestimate their chances of dying from 
breast cancer and the absolute risk reduction of breast can-
cer screening [4, 5]. Many patients also believe that in the 
context of life-threatening disease, more treatment is better 
than less.
Various decision aids such as Adjuvant! On-line were 
designed to help clinicians determine and discuss treatment 
recommendations. Studies show, however, that patients’ 
numeracy profoundly affects their ability to interpret numer-
ical estimates of treatment efficacy [6]. In the UK, NHS 
Predict V2.1 is a prognostication and treatment benefit tool 
providing survival estimates 5 and 10 years following sur-
gery with and without adjuvant therapy (hormone therapy, 
chemotherapy and trastuzumab) [7]. Clinicians can show 
patients relevant information with text, graphs, charts or in 
icon arrays. Clinico-pathologic features of the tumour are 
good prognostic indicators for most patients, but for some, 
the additional assessment of the risk of recurrence, not just 
survival estimates, is also pertinent for decision-making. 
Linking such decision-aid information to other factors that 
might determine treatment recommendations can be confus-
ing for patients.
Several gene expression profiling (GEP) tests including 
 EndoPredict® (EPclin score), Oncotype  DX® Breast Recur-
rence Score and  Prosigna® are approved to guide adjuvant 
chemotherapy decisions for patients with oestrogen recep-
tor (ER)-positive, human epidermal growth factor receptor 
2 (HER2)-negative and lymph node (LN)-negative breast 
cancer. Discussing the classifications of high, intermediate 
or low risk are somewhat illusory as all GEP recurrence 
RSs are on a continuum with their cut-offs based on clinical 
trial data. In one survey, a third of women receiving risk of 
recurrence test results did not fully understand these discus-
sions [8]. Health literacy may affect patients’ retention of 
RS test results, their capacity for processing information, 
understanding and decision-making [5]. Results from a study 
examining patients’ understanding and preferences for six 
different Oncotype DX risk score formats of increasing com-
plexity showed high error rates irrespective of health literacy 
or numeracy [9].
Even when RSs suggest high or low risk of recurrence, 
interpretation of these is subject to various unconscious 
biases. The personality characteristics of patients and doc-
tors, especially their tolerance of uncertainty, may contrib-
ute to indecision or seemingly irrational choices [10]. Clini-
cians less tolerant of uncertainty may, when encountering 
ambiguous clinical situations, order more diagnostic tests 
or extra treatments than colleagues who are more accepting 
[11]. Furthermore, they may be less likely to discuss uncer-
tainty openly with patients or engage in shared decision-
making [12, 13]. Anxious patients with lower tolerances 
of ambiguity are often uncomfortable forgoing all possible 
treatments including chemotherapy even if benefits are mod-
est or negligible.
Consequently health care professionals (HCPs) require 
personal numeracy expertise and wide repertoires of com-
munication skills when explaining concepts to patients crav-
ing certainty about their prognoses and treatment outcomes.
As clinicians admit to communication difficulties when 
discussing GEP test scores, we developed an 8-h educa-
tional program—Talking About Risk in the context of 
GEnomic Tests (TARGET). The intervention’s central aim 
was to assist HCPs when communicating OncotypeDX® and 
 EndoPredict® results thus helping their patients to receive 
clearer information about putative adjuvant chemotherapy 
benefits permitting more educated shared decision-making.
Workshop development and contents
Research shows that improving both the competence and 
the self-confidence of HCPs are necessary prerequisites for 
the effectiveness of educational initiatives and transfer of 
skills into a clinic setting. Programs must include areas that 
enhance skills development (SD), knowledge acquisition 
(KA) and personal awareness (PA) [14–16].
We developed training materials following review of the 
risk literature and discussions with key clinicians and sci-
entists. We mapped out the difficulties encountered explain-
ing high, intermediate and low RSs together with the added 
challenges faced when communicating with patients with 
diverse personality and socio-educational characteristics. 
Other difficulties included developing understandable 
explanations that survival following adjuvant treatments is 
dependent on the risk of distant recurrence of breast cancer, 
how to transform percentages into different graphical rep-
resentations, translating risks of recurrence into simple but 
non-patronising language, and the pros and cons of using 
analogies to describe risk.
We rehearsed patient simulators (actors) experienced in 
improvisation to create different characters and filmed their 
unscripted GEP test result consultations with cancer clini-
cians. This methodology had proved successful in our edu-
cational initiatives improving communication about clinical 
trials [17, 18]. TARGET workshop components and their 
educational aims are shown in Table 1.
Workshops lasted approximately 8 h and were facilitator-
led encouraging group discussion between participants about 
the specific communication skills displayed by oncologists 
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in different scenarios, and practical exercises on different 
means of conveying risk information needed for decision-
making and handling varied patient reactions. Workshops 
concluded with attendees generating lists of optimal and 
necessary points that must be covered when discussing GEP 
test results.
After designing, piloting and refining the program, we 
conducted an evaluation of its efficacy and acceptability with 
HCPs actively engaged in discussing RSs.
Methods
Participants
Participants based in the UK were recruited through 
SHORE-C website adverts and flyers distributed at breast 
cancer meetings following presentations showcasing filmed 
materials. Workshops were accredited 9 Continuing Profes-
sional Development (CPD) points from the Royal College 
of Physicians. Brighton & Sussex Medical School Regional 
Ethics Committee approved and sponsored the study (ref: 
ER/RMLS21/1) funded by the Breast Cancer Research 
Foundation.
Assessments
On the morning prior to and the afternoon following the 
workshop, participants were recorded explaining RSs 
with simulated patients. Their case studies were based 
on real clinical situations, and included consultations 
with low-risk patients, who nevertheless wished to have 
chemotherapy, and higher risk patients averse to chemo-
therapy. Before recording, participants read their assess-
ment case study, the GEP test result, and any associated 
reports, printed handouts or additional information which 
they normally used in their own clinical practice, such as 
Predict outputs. They could access computer notes and dis-
plays if required. All simulated patients were experienced 
in improvisation and well briefed about breast cancer, its 
symptoms and reasons for the consultation. To enhance 
authenticity, different actors and scenarios were used pre 
and post workshop.
Participants gave written consent to all assessments 
prior to the first recording.
Assessments of recorded interviews
There were three separate assessments of all digitally 
recorded interviews: (1) objective assessment by trained 
researchers, (2) self-assessment by attendees and (3) 
patient simulator assessment.
An independent data manager assigned random num-
bers to each digital interview which researchers assessed 
using a study-specific checklist, blinded to assessment time 
point. Researchers’ coding involved checking the presence 
of 17 key communication and information areas, together 
with the HCP’s competence (‘did not do this’, ‘not very 
well’, ‘reasonably well’, ‘very well’). Areas covered issues 
such as explaining the patient’s risk of recurrence with 
and without treatment, implications for survival, making 
appropriate use of print outs/graphs to aid understanding 
about RSs and other general communication behaviours 
including structuring and summarising information.
Following each recorded interview, HCPs self-rated 
their performances on all 17 areas, and how satisfied and 
confident they felt with their interviews and chemotherapy 
decisions.
Post interview, simulated patients also scored their 
HCP’s communication skills on the same 17 items, indi-
cated the decision made and provided general comments 
for feedback.









Introduction An interactive session with a lecture about the psychology of risk and uncertainty and group 
exercises on basic numeracy, tolerance of uncertainty and frequency descriptors of numeri-
cal concepts
√ √
Module 1 An interview with a basic scientist about the principles underpinning GEP tests √ √
Module 2 2 scenarios in which 2 oncologists discuss a high and a low risk,  EndoPredict® test results 
with patients
√ √ √
Module 3 3 scenarios in which different oncologists and a specialist nurse discuss low, intermediate and 
high OncotypeDX® RSs
√ √ √
Module 4 2 further OncotypeDX® scenarios filmed following the publication of the TAILORx trial 
which changed some of the cut-offs and classifications of risk
√ √ √
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Self‑confidence questionnaires
Instruments similar to those used in previous assessments 
of our educational interventions [17, 18] were adapted for 
attendees to self-rate their confidence pre and post workshop 
when discussing 9 general aspects of RSs on a scale from 0 
(none) to 10 (very confident).
Self‑awareness, numeracy and communication 
exercises
During the interactive lecture on risk and uncertainty, attend-
ees completed three exercises: (1) measurement of their own 
predisposition towards uncertainty, (2) a basic numeracy test 
and (3) an exercise about verbal descriptors of frequencies.
(1) The Intolerance of Uncertainty Scale (IUS) measures 
responses to uncertainty, ambiguous situations and the 
future [19]. Intolerance of uncertainty is the tendency 
to consider possibilities of a negative event as unac-
ceptable and threatening irrespective of the probability 
of its occurrence. Individuals with high intolerances 
attempt to make seemingly less risky choices, so the 
scale has utility when examining HCPs’ decision-mak-
ing behaviours.
(2) Basic numeracy-related skills, in particular the facility 
to transform probabilities into proportions, proportions 
into percentages and vice versa, are vital when helping 
patients to understand risk. Participants completed a 
basic numeracy assessment (based on Schwartz) prob-
ing their numeracy abilities [20].
(3) Attendees also completed a short exercise examining 
frequencies and verbal descriptors. They imagined 
a fictitious drug for indigestion and indicated how 
many people out of 100 might get various side effects 
described as ‘fairly common’, ‘often’, ‘unlikely’ and 
‘very rare’.
At the workshop conclusion, attendees rated the quality 
of the educational materials, specific aspects of the content, 
and whether or not they would recommend the program to 
colleagues.
Hypotheses
Our a priori hypotheses were that post workshop (a) attend-
ees’ communication when discussing GEP test results would 
improve, namely that their competence would be measurably 
better, and (b) that they would feel more confident conduct-
ing these interviews, that is, their self-efficacy/self-confi-
dence would be enhanced.
Statistical analyses
As the primary objective outcome was the analysis of partic-
ipants’ digitally recorded interviews with simulated patients, 
pre and post workshop, each of the two researchers cod-
ing interviews performed rate–rerate reliability checks on 
their own assessments and inter-coder reliability checks for 
10% of each other’s interviews. Both rate–rerate and inter-
coder reliability were examined using Kappa coefficients. 
A conditional logistic regression model was used to com-
pare pre- and post-workshop scores for confidence levels 
and for the presence and competent handling of each key 
communication item, using a numeric score for responses 
0 (did not do this), 1 (not very well), 2 (reasonably well), 3 
(very well). This model estimates, for each individual, the 
probability that a score is observed post workshop rather 
than before it. This probability is expressed in terms of the 
difference between pre- and post-scores. The parameter of 
interest in the model is the odds ratio (OR). The larger the 
OR, the more likely it is that higher scores are observed post 
workshop. No distributional assumptions are required for 
the scores. Thus, this approach provides a robust method 
for before-and-after comparisons. The key data used by the 
estimation procedure are numbers of attendees with differ-
ent scores at the two time points. Large positive ORs occur 
when changes fall towards larger score values rather than 
smaller values. Each item reflects a distinctive communica-
tion area, the interpretation of which is of interest on its own. 
We do not make an overall communication recommendation 
based on amalgamation of all items; neither do we control 
the overall error rate. Consequently, corrections for multiple 
testing are not necessary. The results are exploratory and all 
inferential statements are valid marginally; that is, they are 
to be interpreted individually for each item [21, 22].
We also analysed the levels of agreement between (a) 
coder and HCP, (b) coder and actor and (c) actor and HCP 
on their assessment of competence for every information 
area post workshop. For each of the communication areas, 
firstly the rating was dichotomised as (0 = ‘did not do this’ 
or ‘not very well’ and 1=‘reasonably well’ or ‘very well’), 
and secondly a binary variable was formulated to indicate 
agreement (1 = Yes, 0 = No) between each pair of raters for 
each recording. We used a logistic regression model for this 
variable to estimate an overall odds of agreement in each 
information area considered. To yield chance-corrected 
measures of agreement, models incorporated corrections for 
chance agreement in the linear predictor following Lipsitz 
et al. [23]. The total score for Intolerance of Uncertainty 
Scale was analysed using a linear regression model with 
attendees’ levels of confidence on each area of information 
as explanatory variables.
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Results
Between March and July 2018, seven workshops were 
attended by 65 breast cancer specialists (38 women; 27 
men), of whom 32 were oncologists, 24 surgeons and 9 
nurses.
Analyses of digital recordings
The inter-rater (two coders) and rate–rerate reliability 
showed good agreement (k = .9123; SE = .0712; k = .8101, 
SE = .1517 , respectively). A descriptive analysis of pre- and 
post-workshop scores (supplementary Tables D–G) show the 
trends of improvement in most communication areas and 
HCP self-reported confidence overall by speciality.
Participants’ objectively assessed competence when com-
municating with patients about GEP test scores improved 
significantly post workshop (Fig. 1 and Supplementary 
Table A). Significant changes were recorded by coders for 
the majority of key information areas and in structuring 
discussions. There was also a positive overall significant 
median change.
The odds ratios for the simulated patients’ ratings of 
attendees’ 17 key communication behaviours (Fig. 2 and 
Supplementary Table B) show many positive changes 
including structuring interviews, when explaining the 
purpose of GEP tests and the risk of recurrence results. 
Similarly participants’ self-ratings of their communication 
skills were significantly higher post workshop (Fig. 3 and 
Supplementary Table C).
High levels of agreement (concordance) were observed 
between coders, HCPs and simulated patients for ratings 
of “reasonably well” and “very well” responses across the 
17 items. There were too few disagreements in these data 
for some items to make any further analyses of agreement 
worthwhile.
Attendees expressed significantly higher levels of confi-
dence with their discussions following post-workshop inter-
views (OR 3.27; 95% CI 1.53–6.99; P = .0022).
Intolerance of Uncertainty Scale (IUS)
Participants’ mean IUS score was in the normal range but 
12/65 (18%) had high scores, 7 of whom were extremely 
intolerant of uncertainty (Supplementary table H). 
Higher intolerance of uncertainty was associated with 
lower self-rated confidence when discussing prognosis 
with patients with EBC and when discussing intermedi-
ate RSs (beta = − 1.67; 95% CI − 2.89 to − .45; P = .009; 
beta = − 1.76; 95% CI − 3.15 to − 0.37, P = .016). Higher 
intolerance of uncertainty scores was also associated with 
higher levels of self-rated confidence when discussing high 
RSs generally and when communicating with patients of 
Fig. 1  Objective analysis of recordings. Forest plot shows odds ratios (95% confidence intervals) of improved scores including overall median 
score
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Fig. 2  Odds ratios (95% confidence intervals) of improved scores for simulated patients’ assessment of communication behaviours including 
overall median score
Fig. 3  Odds ratios (95% confidence intervals) of improved scores for HCPs’ assessment of communication behaviours including overall median 
score
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lower socio-educational background (beta = 1.81; 95% 
CI 0.16–3.45; P = .035; beta = 1.95; 95% CI 0.18–3.72, 
P = .035.)
Basic numeracy
Correct responses to the basic numeracy items are shown in 
Table 2. The poorest performance (only 58% correct) was for 
question 3—calculating the expected frequency of an event 
based on its probability of occurrence.
Frequency and verbal descriptors
Participants attributed wide numerical ranges to the differ-
ent verbal descriptors: The term ‘fairly common’ elicited 
a range from 10/100 to 90/100; likewise ‘often’ produced 
estimates ranged from 1 to 90, ‘unlikely’ 0.1 to 30 and ‘very 
rare’ 0.01 to 10.
General self‑confidence
Figure 4 shows significant improvements in attendees’ self-
confidence for all 9 items—probing prognosis in general, 
when handling patients with different RSs and those from 
different socio-educational backgrounds and with varied 
emotional responses.
Feedback at workshop completion revealed that most 
attendees found TARGET useful (9.6/10), informative 
9.6/10) and enjoyable (9.7/10) and 100% would ‘definitely’ 
recommend the program to their colleagues.
Discussion
This intervention was designed specifically to assist HCPs 
when discussing GEP test scores with patients and implica-
tions these have for adjuvant chemotherapy recommenda-
tions. There are many generic aspects of the program which 
are suitable for any HCP tasked with explaining risk to 
patients.
TARGET was based on successful evidence-based educa-
tional packages that contain elements enhancing knowledge 
acquisition, skills development and self-awareness [17, 18]. 
Prior research shows that interventions which change both 
competence and self-confidence/efficacy often transfer suc-
cessfully into a clinical setting and are enduring [14, 15]. 
Objective analyses of attendees’ pre- and post-workshop 
interviews revealed positive behavioural changes in the style 
and content of discussions and an increase in HCPs’ reported 
self-confidence.
An important feature of TARGET was enhancement of 
attendees’ personal awareness about their own numeracy 
Table 2  Results from the basic numeracy exercise
N = 65 (%)
1 A person taking Drug A has a 1% chance of an allergic reaction. If 1000 people take the drug, how many will have a reaction? 
(10)
63 (97%)
2 A person taking Drug B has a 1 in a 1000 chance of an allergic reaction. What % of people taking the drug will have a reac-
tion? (0.1%)
54 (83%)
3 The chance of getting a serious viral infection is 0.0005. How many of 10,000 exposed people might get the infection? (5) 38 (58%)
4 Imagine I flip a fair coin 1000 times. How many times will the coin land heads up? (500) 55 (85%)
Fig. 4  Odds ratios (95% confidence intervals) of improved confidence levels post workshop
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skills and attitudes to uncertainty. Conversations with 
patients about the rationale and logic for different manage-
ment policies requires discussion about the potential risks 
and benefits of adjuvant treatments aimed at reducing recur-
rence, and the impact that recurrence has on survival. Dur-
ing such discussions many different numbers are provide in 
dissimilar formats. Numeracy skills of general populations 
in the US and UK are often poor, and many get confused by 
numbers with different denominators and experience dif-
ficulties with percentages [24]. Studies show that even with 
decision aids that include graphs, bar charts and icon arrays, 
some patients have difficulty identifying their own personal 
risks [25]. It is really important therefore that HCPs com-
municating risk information can transform numbers into for-
mats appropriate for individual patients in order to truly per-
mit shared/collaborative decision-making. Some TARGET 
attendees, in common with many highly educated people, 
had personal numeracy difficulties [26], in particular prob-
lems converting percentages into proportions, proportions 
into percentages and calculating expected frequencies from 
probabilities.
Using verbal descriptors seems a reasonable way to cir-
cumvent numeracy difficulties. Attendees’ responses to the 
verbal descriptors for common side effect exercise demon-
strated widely differing ranges. This revealed the pitfalls if, 
when discussing risk, numbers are avoided altogether and 
communicators rely instead on verbal descriptors or frequen-
cies. There is no way of knowing if either their colleagues’ 
or patients’ interpretations of phrases such as ‘fairly com-
mon’ would match their own. The European drug regula-
tory agency (EMA) has definitions for numbers that should 
be associated with words relating to side effect frequencies 
and the Royal College of Anaesthetists has produced pic-
torial charts assisting understanding about risk, e.g. ‘rare’ 
is described as 1:10,000, with a sketch and description of 
‘someone in a small town’ [27].
Ambiguity about management options can ‘leak’ 
through in obvious and nuanced ways during interviews 
with patients. Interestingly, those attendees with a high 
intolerance of uncertainty had lower levels of confidence 
when discussing intermediate risk of recurrence scores with 
patients. In clinic settings, these HCPs would be more likely 
to prescribe chemotherapy especially when faced with an 
anxious patient, also intolerant of uncertainty, and who had 
an intermediate or borderline risk score.
One limitation of this work is that unless communication 
skills programs are made a mandatory part of training, then 
HCPs who attend workshops maybe a self-selected group, 
although we saw that the baseline skills of participants 
ranged widely. TARGET workshops lasted 8 h, split over 
2 days but could be adapted for shorter modular-based deliv-
ery, lasting 2 h per module. It is unknown whether or not this 
would produce the same improvements. To assist with wider 
dissemination, we have produced a facilitator handbook with 
time-coded transcripts of scenarios enabling facilitators to 
stop at key points and engage groups in exercises or discus-
sions. There are suggested prompts and comments about 
the issues illustrated and for less experienced facilitators, 
examples of structuring teaching sessions. Facilitator train-
ing programs are currently being held.
Although TARGET focussed on OncotypeDX® and 
 EndoPredict® RSs, other available GEP tests share similar 
communication challenges. Discussing risk and managing 
the understandable anxiety and uncertainty of women about 
their need for adjuvant chemotherapy and ultimate decision-
making demands a wide repertoire of communication skills 
that TARGET workshops appeared to enrich.
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